204 related articles for article (PubMed ID: 18053091)
1. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells.
Susick L; Veluthakal R; Suresh MV; Hadden T; Kowluru A
J Cell Mol Med; 2008; 12(5A):1571-83. PubMed ID: 18053091
[TBL] [Abstract][Full Text] [Related]
2. Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells.
Yu Z; Kone BC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F496-502. PubMed ID: 16174862
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells.
Larsen L; Tonnesen M; Ronn SG; Størling J; Jørgensen S; Mascagni P; Dinarello CA; Billestrup N; Mandrup-Poulsen T
Diabetologia; 2007 Apr; 50(4):779-89. PubMed ID: 17265033
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
[TBL] [Abstract][Full Text] [Related]
5. Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells.
Pedersen SS; Prause M; Williams K; Barrès R; Billestrup N
J Biol Chem; 2022 Sep; 298(9):102312. PubMed ID: 35921894
[TBL] [Abstract][Full Text] [Related]
6. IL-1beta-induced iNOS expression, NO release and loss in metabolic cell viability are resistant to inhibitors of ceramide synthase and sphingomyelinase in INS 832/13 cells.
Veluthakal R; Jangati GR; Kowluru A
JOP; 2006 Nov; 7(6):593-601. PubMed ID: 17095838
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
8. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.
Lewis EC; Blaabjerg L; Størling J; Ronn SG; Mascagni P; Dinarello CA; Mandrup-Poulsen T
Mol Med; 2011; 17(5-6):369-77. PubMed ID: 21193899
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors.
Hämäläinen M; Lilja R; Kankaanranta H; Moilanen E
Pulm Pharmacol Ther; 2008; 21(2):331-9. PubMed ID: 17913526
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.
Kim EK; Kwon KB; Song MY; Han MJ; Lee JH; Lee YR; Lee JH; Ryu DG; Park BH; Park JW
Pancreas; 2007 Nov; 35(4):e1-9. PubMed ID: 18090225
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
12. Fructus Xanthii extract protects against cytokine-induced damage in pancreatic beta-cells through suppression of NF-kappaB activation.
Song MY; Kim EK; Lee HJ; Park JW; Ryu DG; Kwon KB; Park BH
Int J Mol Med; 2009 Apr; 23(4):547-53. PubMed ID: 19288032
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide.
Arafat HA; Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Dafoe DC
Endocrinology; 2007 Feb; 148(2):575-84. PubMed ID: 17110428
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells.
Carpenter L; Cordery D; Biden TJ
J Biol Chem; 2001 Feb; 276(7):5368-74. PubMed ID: 11087760
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa.
Waterborg JH; Kapros T
Biochem Cell Biol; 2002; 80(3):279-93. PubMed ID: 12123281
[TBL] [Abstract][Full Text] [Related]
16. Coptidis rhizoma extract protects against cytokine-induced death of pancreatic beta-cells through suppression of NF-kappaB activation.
Kim EK; Kwon KB; Han MJ; Song MY; Lee JH; Lv N; Ka SO; Yeom SR; Kwon YD; Ryu DG; Kim KS; Park JW; Park R; Park BH
Exp Mol Med; 2007 Apr; 39(2):149-59. PubMed ID: 17464176
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
Han SB; Lee JK
Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain.
Im H; Grass JA; Christensen HM; Perkins A; Bresnick EH
Biochemistry; 2002 Dec; 41(51):15152-60. PubMed ID: 12484752
[TBL] [Abstract][Full Text] [Related]
19. Radix asari extract protects pancreatic beta cells against cytokine-induced toxicity: implication of the NF-kappaB-iNOS signaling cascade.
Song MY; Kim KA; Lee SY; Kim EK; Lv N; Lee JH; Park JW; Ryu DG; Kwon KB; Park BH
Int J Mol Med; 2007 Nov; 20(5):769-75. PubMed ID: 17912472
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.
Chabane N; Zayed N; Afif H; Mfuna-Endam L; Benderdour M; Boileau C; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Osteoarthritis Cartilage; 2008 Oct; 16(10):1267-74. PubMed ID: 18417374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
